Soufflé Therapeutics

📍 Boston, United States🗓 Founded 2021👥 83 employees💰 Last funded Jan 2023
Biotechnology🌐 souffletx.com
Website LinkedIn
We share a vision that potent, precise and safe medicines can be designed and developed for all diseases. Soufflé discovers and develops cell-specific ligands to deliver siRNA-based medicines that are rationally designed and transferred across the cell membrane to their target. We combine multiple proprietary technologies for identification of cell-specific receptors, ligand optimization and potent siRNA engineering to create and commercialize safer, stronger, and more durable medicines which will help improve patient lives.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Soufflé Therapeutics?
Soufflé Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Soufflé Therapeutics last raise funding?
The most recent investment in Soufflé Therapeutics recorded on gritt.io was in January 2023.
When was Soufflé Therapeutics founded?
Soufflé Therapeutics was founded in 2021.
What industry is Soufflé Therapeutics in?
Soufflé Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Soufflé Therapeutics based?
Soufflé Therapeutics is headquartered in Boston, United States.